Methods of administering elagolix | Patent Publication Number 20210275527

US 20210275527 A1
Patent NumberUS 11690845 B2
Application Number17004817
Filled DateAug 27, 2020
Priority DateMar 5, 2020
Publication DateSep 9, 2021
Original AssigneeAbbvie Inc.
Current AssigneeAbbvie Inc.
Inventor/ApplicantsAkshanth R. Polepally
Farah N. Ali
Ahmed Nader
Nael M. Mostafa
Sheetal P. Dharia
Mohamad Shebley
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.